Monoclonal Antibodies

Research on monoclonal antibodies described by J.L. Kovach and colleagues

Published in Surgery Litigation and Law Weekly, March 6th, 2009

"A patient presented with subfoveal choroidal neovascularization associated with angioid streaks and was created with three intravitreal injections of off-label bevacizumab (1.25 mg) in the right eye," scientists in the United States report.

"Visual acuity improved front 20/70 to 20/20 and remained at this level for 32 months. In certain patients with choroidal neovascularization from angioid streaks, intravitreal bevacizumab ilia produce normalization of visual acuity and macular anatomy for an extended period of time," wrote J.L. Kovach and colleagues.

The researchers concluded: "[Ophthalmic Surg Lasers Imaging 2009;40:77-79.]'."

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly

Source: Surgery Litigation and Law Weekly (2009-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry